MTOR and head and neck squamous cell carcinoma: The cancer genome atlas (TCGA) study has revealed that a greater number of the head and neck squamous cell carcinoma (HNSCC) cases have shown an alteration in the protein kinase B (AKT)/ mammalian target of rapamycin (mTOR) pathway [11].